With this functional modulation, LEN significantly downregulates IKZF1/3 and exerts its therapeutic action on the patients of MM and 5q-deletion myelodysplastic syndrome (5q-MDS) (9, 10). Here, IKZF1 is linked to Miyoshi myopathy.